Actively Recruiting
Comparing Clareon PanOptix and AcrySof PanOptix Intraocular Lenses for Better Contrast Sensitivity After Cataract Surgery
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-03-30
40
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are comparing two types of intraocular lenses IOLs, Clareon PanOptix CPO and AcrySof PanOptix APO, in patients undergoing cataract surgery who want correction for presbyopia. This prospective, randomized, single-center study aims to show whether contrast sensitivity is better with the CPO lens three months after implantation. The study involves implanting one type of lens in each eye of the same patient to directly compare results. Both eyes of each patient will be implanted with either the CPO or APO multifocal IOL, including toric and non-toric versions. Patients have routine follow-up visits at days 3 to 10 and at one month with no extra tests. At three months, which marks the end of the clinical investigation, participants will have additional contrast sensitivity and non-invasive aberrometry tests as part of the study procedures. Participants will be monitored through standard postoperative visits, with key assessments including contrast sensitivity at three months, visual acuity at various distances, refractive stability, objective scatter index, and presence of glistenings. The study will last at least three months post-implantation, and all procedures align with routine clinical care practices. Participants are expected to provide informed consent and be affiliated with a social security scheme.
CONDITIONS
Brief Title
Clareon PanOptix Versus AcrySof PanOptix : Prospective Study Comparing Contrast Sensitivity
Research Team
D
Dominique MONNET, MD, PhD
V
Valérie PLENCE, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here